CClinicalTrials.gg
CompletedNCT05597371Updated Feb 24, 2026

An Analysis in the Use of Telecommunication Platform

An observational study in the Use of the Platform, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Per ClinicalTrials.gov, last updated 2026-02-24.

Sponsored by National Taiwan University Hospital · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Retrospective
Enrollment
1,000,000
Sex
All
01

Study summary

The COVID-19 pandemic becomes a global challenge. Beneficial to being an island country and having appropriate policies, there were only few imported cases in Taiwan. However, many locally acquired cases came out in the mid of this May. The hospital policy about containing infection changed accordingly.

A real-time communication platform for the health care workers was designed and embedded in the hospital information system of the emergency department in 2018. The functions included sending messages to certain staff, pop-up reminders, and tracking messages. This study aims to evaluate the use of the communication platform during the COVID pandemic.

Read the detailed description

The COVID-19 pandemic becomes a global challenge. Beneficial to being an island country and having appropriate policies, there were only few imported cases in Taiwan. However, many locally acquired cases came out in the mid of this May. The hospital policy about containing infection changed accordingly.

A real-time communication platform for the health care workers was designed and embedded in the hospital information system of the emergency department in 2018. The functions included sending messages to certain staff, pop-up reminders, and tracking messages. This study aims to evaluate the use of the communication platform during the COVID pandemic.

02

Conditions studied

  • the Use of the Platform
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

ED visits of the emergency department of the National Taiwan University Hospital

Inclusion criteria

healthcare workers with using the communication platform.

Exclusion criteria

Exclusion Criteria:

healthcare workers without using the communication platform.

05

Study design

Observational model
Ecologic or community
Time perspective
Retrospective
Enrollment
1,000,000 participants (actual)
Patient registry
No

Interventions

  • Otherthe use of the platform

    the use of the platform

06

What researchers measure

Primary outcomes

  1. the number of the use of the communication platform during the COVID pandemic

    the number of the use was divided by the visits

    Time frame: from 2018 to 2022

07

Study locations

1 site
  • Department of Emergency Medicine, National Taiwan University Hospital
    Taipei, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05597371
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Oct 28, 2022
Start date
Jan 1, 2018
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025
Last update
Feb 24, 2026

Study contacts

Wan-Ching Lien
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion